NeuroScreen-EEG

(AI-powered EEG-based Early Brain Abnormality & Tumor-Risk Screening Tool)

Overview

NeuroScreen-EEG is an AI-assisted EEG analysis platform is a non-invasive, AI-assisted EEG screening platform that detects early functional abnormalities and tumor-risk indicators, enabling timely referral for neuroimaging.

Key Benefits

Faster Diagnosis & Screening Support
Low-Cost & Non-Invasive
AI - Drive Analytics Platform
Reduced Clinician Workload
Customizable & Scalable

Features

AI-Based Brain Abnormality Detection
Focal Dysfunction & Localization Analysis
Cognitive & Neurological Analytics
Explainable AI for Clinical Trust
Multi-modal EEG Signal Processing

Specifications

Ability to Process Live Signals
Capable to afford 10-20 Electrodes data
Deep-tech Signal and AI Modeling
API integration available
Interactive Web-based dashboard
On-premise and Cloud Deployable

Use Cases

Hospitals & Clinics
Research Labs
Mental Health Centers
Brain Health Screening
Academic Institutions

Why NeuroScreen-EEG

NeuroScreen-EEG supports and accelerate the diagnostic pathway by identifying early functional abnormalities and risk indicators from routine EEG recordings. By enabling faster triage, prioritizing high-risk cases for imaging or specialist referral, and providing explainable insights to clinicians, the system helps reduce diagnostic delays, optimize clinical resources, and improve patient outcomes—especially in high-volume, low-resource, and time-critical environments.

Clinical Disclaimer: This product is intended as an AI-assisted screening and decision-support tool. It does not replace clinical judgment or medical imaging and is not intended for standalone diagnosis.